Professor Michael Stowasser
Researcher biography
MS has >30 years of clinical research experience in pathogenesis and management of hypertension (HT) and especially of endocrine varieties including primary aldosteronism (PA). Working within the Greenslopes Hospital Hypertension Unit (GHHU), he played a significant role in the demonstration that PA is much more common than previously thought, and in the description of a new familial form (FH-II). MS has made key contributions to understanding of steroid and BP regulation in another familial form (FH-I). The combined GHHU/Princess Alexandra Hospital HT Unit (PAHHU, which MS set up in 2000) has the largest series (>2000) worldwide of patients with PA who have been thoroughly documented and meticulously studied, helping MS to become internationally recognized as an authority on pathogenesis (including genetics), diagnostic workup and management of PA, including its familial forms. In 2006, he was invited to be a member of an international Task Force sponsored by the US Endocrine Society to develop clinical guidelines for the diagnosis and management of PA.
As at October 2018, MS had published or in press 205 full papers in peer-reviewed journals, 15 chapters for textbooks of medicine (including DeGroot's Endocrinology) and four on-line chapters (including one for Harrison's Online). According to ISI Web of Knowledge, MS's journal publications have been cited >7000 times. Fifteen have been cited >100 times, one of these >900 ("h" index 44). He has been invited to speak at major meetings 120 times (84 international, 36 national) since 1998 including a debate with Norman Kaplan on the prevalence of PA (ISH, Prague 2002). He was invited by the University of WA to give the Robert Vandongen Memorial Lecture for 2002 and by the Cardiac Society of Australia and New Zealand to deliver the Gaston-Bauer Lecture in 2012. MS has collaborated with researchers in 14 international Units and all Australian states. In 2002, he was named as a Chief Investigator within a newly established Clinical Centre of Research Excellence (CCRE) in Cardiovascular Disease and Metabolic Disorders at Princess Alexandra Hospital, funding for which was renewed by the NHMRC in 2006 for 2007-11. In 2018 he became one of six international investigators to head a Transatlantic Network of Excellence investigating Potassium and Hypertension funded by the Leducq Foundation. Has served on Editorial Boards for J Hypertens, Clin Exper Physiol Pharmacol, Nephrology (Subject Editor), J Clin Endocrinol Metab and J Hum Hypertens (Co-Editor) and assessed manuscripts for >20 major international journals. Has served as written grant application assessor for six major international and five major national funding bodies, on NHF Grant Interviewing Committees in 1997, 1998, 1999, 2001 and 2002, and on NHMRC GRPs in 2003, 2005, 2006, 2007, 2008, 2010 and 2011. MS is a member of the International Society of Hypertension (ISH), American Society of Hypertension and US Endocrine Society. He was elected into the Executive Committee of the High BP Research Council of Australia in 1998, as Secretary in 2001 and as President in 2017. He also served as President of the Asia-Pacific Society of Hypertension in 2019. He was a Member of the NHF BP and Vascular Disease Advisory Committee from 1998 until 2012.
Other Awards and Honours:
NHMRC Postgraduate Medical Research Scholarship, 1992-94 John W.H. Tyrer Prize for Research in Internal Medicine, 1992 NHF Clinical Research Fellowship, 1995-97 NHF Postdoctoral Fellowship, 1998-99 Honorary Professor to the Xinjiang Institute of Hypertension, 2005 Member, Primary Aldosteronism Guidelines Task Force, US Endocrine Society, 2006 Visiting Professor, Tung Wah Eastern Hospital, Hong Kong, 2008 Honorary Professor of the Hypertension Department at Henan Provincial People's Hospital, the Hypertension Control and Research Center of Henan Province, and the Hypertension Diagnosis and Treatment Center of Henan Province, 2009 Gaston Bauer Lecturer, Cardiac Society of Australia and New Zealand, 2012